Caribou Biosciences Financial Overview
Caribou Biosciences's market cap is currently $202.08M. The company's EPS TTM is $-0.3; its P/E ratio is -1.22; Caribou Biosciences is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
